Epilepsy Trial, Recruiting (NCT06570954)

Epilepsy Trial, Recruiting NCT06570954 Sponsor: University of Alabama at Birmingham Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06570954 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 19 years of age or older
You have been diagnosed with psychogenic non-epileptic seizures (seizures that are not caused by abnormal electrical activity in the brain) by a doctor, confirmed through a brain monitoring test with video recording (video-EEG)

Who may not be able to join:

You have also been diagnosed with epilepsy
You have fewer than 4 of these seizure episodes per month
Your episodes are caused by something other than psychogenic non-epileptic seizures, such as reduced blood flow to the brain, a sleep disorder, or migraines
You are currently taking part in another form of therapy during the study period
You have a severe intellectual disability
You experience severe mental health symptoms such as hallucinations (seeing or hearing things that are not there) or delusions (strongly held false beliefs)
Your blood pressure is above 130/80 mmHg (this applies specifically to one part of the trial — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aaron Fobian, PhD, University of Alabama at Birmingham

Phone: 205-934-2241

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06570954

Sponsor: University of Alabama at Birmingham

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 205-934-2241

More information: https://clinicaltrials.gov/study/NCT06570954

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 19 years of age or older
You have been diagnosed with psychogenic non-epileptic seizures (seizures that are not caused by abnormal electrical activity in the brain) by a doctor, confirmed through a brain monitoring test with video recording (video-EEG)

Who may not be able to join:

You have also been diagnosed with epilepsy
You have fewer than 4 of these seizure episodes per month
Your episodes are caused by something other than psychogenic non-epileptic seizures, such as reduced blood flow to the brain, a sleep disorder, or migraines
You are currently taking part in another form of therapy during the study period
You have a severe intellectual disability
You experience severe mental health symptoms such as hallucinations (seeing or hearing things that are not there) or delusions (strongly held false beliefs)
Your blood pressure is above 130/80 mmHg (this applies specifically to one part of the trial — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Alabama at Birmingham

Registry

ClinicalTrials.gov

Start date

10 April 2025

Est. completion

1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Magic and turbulence task; Pain catastrophizing scale- situation specific; Pain tolerance (time); Salivary Cortisol; Pain Rating Scale; Stroop task

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov